CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Stock Cash Flow
Canada - TSX-V:CYTO - CA2328211081 - Common Stock
0.23 CAD
+0.01 (+2.22%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -4.62M | -7.86M | -4.64M | -3.68M | -3.24M | |||
| Depreciation Amortization | 790.80K | 707.30K | 512.80K | 364.60K | 295.80K | |||
| Change In Working Capital | 580.30K | -304.30K | 432.10K | -75.30K | -147.00K | |||
| Interest Paid | N/A | 102.20K | 4.60K | 20.10K | 30.50K | |||
| Taxes Paid | N/A | N/A | 0.00 | N/A | N/A | |||
| Other non cash items | -7.30K | 2.69M | 832.10K | 449.50K | 54.30K | |||
| OPERATING CASH FLOW | -3.26M | -4.77M | -2.86M | -2.94M | -3.03M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -466.80K | -1.30M | -162.10K | -380.80K | -333.10K | |||
| Other Investing Activity | -225.00K | 7.62M | -2.46M | N/A | N/A | |||
| INVESTING CASH FLOW | -691.80K | 6.32M | -2.62M | -380.80K | -333.10K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 28.80K | -36.20K | -186.50K | -147.90K | -130.60K | |||
| Stock Issued/Repurchased | -950.00K | 5.00K | 994.80K | 876.10K | 6.81M | |||
| Other Financing Activity | 2.44M | -28.80K | 2.45M | 0.00 | -91.30K | |||
| FINANCING CASH FLOW | 1.52M | -60.00K | 3.26M | 728.30K | 6.58M | |||
| CHANGE IN CASH | -2.43M | 1.49M | -2.21M | -2.60M | 3.22M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -3.26M | -4.77M | -2.86M | -2.94M | -3.03M | |||
| Capital Expenditure | -466.80K | -1.30M | -162.10K | -380.80K | -333.10K | |||
| FREE CASH FLOW | -3.72M | -6.07M | -3.02M | -3.32M | -3.37M | |||
All data in CAD